These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 28509806)

  • 1. Advances in management of hepatocellular carcinoma.
    Allaire M; Nault JC
    Curr Opin Oncol; 2017 Jul; 29(4):288-295. PubMed ID: 28509806
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transarterial chemoembolization in hepatocellular carcinoma treatment: Barcelona clinic liver cancer staging system.
    Han K; Kim JH
    World J Gastroenterol; 2015 Sep; 21(36):10327-35. PubMed ID: 26420959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of hepatocellular carcinoma with portal venous tumor thrombosis: A comprehensive review.
    Han K; Kim JH; Ko GY; Gwon DI; Sung KB
    World J Gastroenterol; 2016 Jan; 22(1):407-16. PubMed ID: 26755886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sorafenib With and Without Transarterial Chemoembolization for Advanced Hepatocellular Carcinoma With Main Portal Vein Tumor Thrombosis: A Retrospective Analysis.
    Zhang Y; Fan W; Wang Y; Lu L; Fu S; Yang J; Huang Y; Yao W; Li J
    Oncologist; 2015 Dec; 20(12):1417-24. PubMed ID: 26446238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of HCC.
    de Lope CR; Tremosini S; Forner A; Reig M; Bruix J
    J Hepatol; 2012; 56 Suppl 1():S75-87. PubMed ID: 22300468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Yttrium-90 radioembolization vs sorafenib for intermediate-locally advanced hepatocellular carcinoma: a cohort study with propensity score analysis.
    Gramenzi A; Golfieri R; Mosconi C; Cappelli A; Granito A; Cucchetti A; Marinelli S; Pettinato C; Erroi V; Fiumana S; Bolondi L; Bernardi M; Trevisani F;
    Liver Int; 2015 Mar; 35(3):1036-47. PubMed ID: 24750853
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment algorithm for intermediate and advanced stage hepatocellular carcinoma: Korea.
    Choi JY
    Oncology; 2011; 81 Suppl 1():141-7. PubMed ID: 22212948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advances in non-surgical management of primary liver cancer.
    Chen X; Liu HP; Li M; Qiao L
    World J Gastroenterol; 2014 Nov; 20(44):16630-8. PubMed ID: 25469032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment and prognostic factors in patients with hepatocellular carcinoma.
    Martins A; Cortez-Pinto H; Marques-Vidal P; Mendes N; Silva S; Fatela N; Glória H; Marinho R; Távora I; Ramalho F; de Moura MC
    Liver Int; 2006 Aug; 26(6):680-7. PubMed ID: 16842324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatocellular carcinoma tumor board: making sense of the technologies.
    Abou-Alfa GK; Marrero J; Renz J; Lencioni R
    Am Soc Clin Oncol Educ Book; 2015; ():e213-20. PubMed ID: 25993176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Challenges of advanced hepatocellular carcinoma.
    Colagrande S; Inghilesi AL; Aburas S; Taliani GG; Nardi C; Marra F
    World J Gastroenterol; 2016 Sep; 22(34):7645-59. PubMed ID: 27678348
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of Hepatocellular Carcinoma: Current Status and Future Directions.
    Au JS; Frenette CT
    Gut Liver; 2015 Jul; 9(4):437-48. PubMed ID: 26087860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the survival and tolerability of radioembolization in elderly vs. younger patients with unresectable hepatocellular carcinoma.
    Golfieri R; Bilbao JI; Carpanese L; Cianni R; Gasparini D; Ezziddin S; Paprottka PM; Fiore F; Cappelli A; Rodriguez M; Ettorre GM; Saltarelli A; Geatti O; Ahmadzadehfar H; Haug AR; Izzo F; Giampalma E; Sangro B; Pizzi G; Notarianni E; Vit A; Wilhelm K; Jakobs TF; Lastoria S;
    J Hepatol; 2013 Oct; 59(4):753-61. PubMed ID: 23707371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent advances in the management of hepatocellular carcinoma.
    Zhang S; Yue M; Shu R; Cheng H; Hu P
    J BUON; 2016; 21(2):307-11. PubMed ID: 27273938
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Favorable survival time provided with radioembolization in hepatocellular carcinoma patients with and without portal vein thrombosis.
    Ozkan ZG; Poyanli A; Ucar A; Kuyumcu S; Akyuz F; Keskin S; Saglam S; Yilmaz E; Karaca C; Turkmen C
    Cancer Biother Radiopharm; 2015 Apr; 30(3):132-8. PubMed ID: 25760644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatocellular carcinoma: current management and recent advances.
    Lau WY; Lai EC
    Hepatobiliary Pancreat Dis Int; 2008 Jun; 7(3):237-57. PubMed ID: 18522878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current treatment strategy for hepatocellular carcinoma.
    Ng KK; Poon RT
    Saudi Med J; 2007 Sep; 28(9):1330-8. PubMed ID: 17768455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent advances in the treatment of hepatocellular carcinoma.
    Singal AG; Marrero JA
    Curr Opin Gastroenterol; 2010 May; 26(3):189-95. PubMed ID: 20224395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transarterial Chemoembolization versus Radiofrequency Ablation for Recurrent Hepatocellular Carcinoma after Resection within Barcelona Clinic Liver Cancer Stage 0/A: A Retrospective Comparative Study.
    Chen R; Gan Y; Ge N; Chen Y; Wang Y; Zhang B; Wang Y; Ye S; Ren Z
    J Vasc Interv Radiol; 2016 Dec; 27(12):1829-1836. PubMed ID: 27553917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent advances in the treatment of hepatocellular carcinoma.
    Padhya KT; Marrero JA; Singal AG
    Curr Opin Gastroenterol; 2013 May; 29(3):285-92. PubMed ID: 23507917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.